Long-term safety of secukinumab in patients with moderate-to-severe plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis: integrated pooled clinical trial and post-mar...

by A. Deodhar, P. J. Mease, I. B. McInnes, X. Baraliakos, K. Reich, A. Blauvelt, C. Leonardi, B. Porter, A. Das Gupta, A. Widmer, L. Pricop, T. Fox
Published 2019-05-01

Use of the interleukin-17A inhibitor secukinumab in psoriatic arthritis: a subanalysis of the Russian population in the international randomized clinical trials FUTURE 1 and FUTURE...

by T. V. Korotaeva, E. G. Zotkin, O. B. Nesmeyanova, N. N. Vezikova, O. B. Ershova, N. V. Izmozzherova, M. S. Petrova, A. A. Kastanyan, S. P. Yakupova, A. S. Agafina, M. L. Stanislav, E. A. Novoderezhkina, E. L. Nasonov, P. J. Mease
Published 2017-04-01